PHAT Phathom Pharmaceuticals, Inc.

NASDAQ
$4.66

Phathom Pharmaceuticals, Inc. (PHAT) Earnings News

Earnings press releases, previews and reviews for Phathom Pharmaceuticals, Inc. (PHAT), newest first. Our most recent is review: Phathom Misses on a Decelerating Quarter as Cash-Flow Progress Collides With a New VOQUEZNA Exclusivity Overhang.